These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

242 related articles for article (PubMed ID: 32435521)

  • 1. Selective granulocyte and monocyte apheresis in inflammatory bowel disease: Its past, present and future.
    Chen XL; Mao JW; Wang YD
    World J Gastrointest Pathophysiol; 2020 May; 11(3):43-56. PubMed ID: 32435521
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Safety and efficacy of granulocyte and monocyte adsorption apheresis in paediatric inflammatory bowel disease: a prospective pilot study.
    Martín de Carpi J; Vilar P; Prieto G; García Novo MD; Ribes C; Varea V
    J Pediatr Gastroenterol Nutr; 2008 Apr; 46(4):386-91. PubMed ID: 18367949
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treating inflammatory bowel disease by adsorptive leucocytapheresis: a desire to treat without drugs.
    Saniabadi AR; Tanaka T; Ohmori T; Sawada K; Yamamoto T; Hanai H
    World J Gastroenterol; 2014 Aug; 20(29):9699-715. PubMed ID: 25110409
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Safety and effectiveness of granulocyte and monocyte adsorptive apheresis in patients with inflammatory bowel disease in special situations: a multicentre cohort study.
    Motoya S; Tanaka H; Shibuya T; Osada T; Yamamoto T; Hongo H; Mizuno C; Saito D; Aoyama N; Kobayashi T; Ito H; Tanida S; Nojima M; Kokuma S; Hosoi E
    BMC Gastroenterol; 2019 Nov; 19(1):196. PubMed ID: 31752695
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ulcerative colitis with hepatitis B virus infection treated successfully by granulocyte monocyte apheresis.
    Saito H; Hanafusa N; Kishikawa J; Noiri E; Sunami E; Ishihara S; Watanabe T; Nangaku M
    J Clin Apher; 2016 Dec; 31(6):584-586. PubMed ID: 26876484
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Retrospective Single Center Study of Granulocyte Monocyte Adsorption Apheresis Treatment in Inflammatory Bowel Disease.
    Edfors K; Ståhlberg D; Söderman C
    Ther Apher Dial; 2016 Feb; 20(1):79-85. PubMed ID: 26841133
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Granulocyte and monocyte apheresis in inflammatory bowel disease: The patients' point of view.
    Rodríguez-Lago I; Benítez JM; García-Sánchez V; Gutiérrez A; Sempere L; Ginard D; Barreiro-de Acosta M; Cabriada JL
    Gastroenterol Hepatol; 2018; 41(7):423-431. PubMed ID: 29739692
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Apheresis: A cell-based therapeutic tool for the inflammatory bowel disease.
    Yasmin F; Najeeb H; Naeem U; Moeed A; Koritala T; Surani S
    World J Clin Cases; 2022 Jul; 10(21):7195-7208. PubMed ID: 36158031
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Granulocyte and Monocyte Apheresis for Induction of Remission in Children With New-Onset Inflammatory Bowel Colitis.
    Rolandsdotter H; Eberhardson M; Fagerberg UL; Finkel Y
    J Pediatr Gastroenterol Nutr; 2018 Jan; 66(1):84-89. PubMed ID: 28604509
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Granulocyte-monocyte adsorptive apheresis in pediatric inflammatory bowel disease: results, practical issues, safety, and future perspectives.
    Ruuska T; Wewer V; Lindgren F; Malmborg P; Lindquist M; Marthinsen L; Browaldh L; Casswall T; Kalliomäki M; Grönlund J
    Inflamm Bowel Dis; 2009 Jul; 15(7):1049-54. PubMed ID: 19137602
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Adsorptive Granulocyte and Monocyte Apheresis Is Effective in Ulcerative Colitis Patients Both with and without Concomitant Prednisolone.
    Matsuda K; Ohno K; Okada Y; Yagi T; Tsukamoto M; Fukushima Y; Horiuchi A; Shimada R; Ozawa T; Hayama T; Tsuchiya T; Tamura J; Iinuma H; Nozawa K; Aoyagi H; Isono A; Abe K; Kodashima S; Yamamoto T; Kawasaki Y; Tamura Y; Sasajima Y; Kondo F; Hashiguchi Y
    Inflamm Intest Dis; 2020 Feb; 5(1):36-41. PubMed ID: 32232053
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dose-intensified granulocyte-monocyte apheresis in therapy refractory ulcerative colitis.
    Schultheiß C; Weischenberg R; Herrmann A; Haller B; Schmid RM; Reindl W; Huber W
    Artif Organs; 2015 Feb; 39(2):187-92. PubMed ID: 24981894
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pyoderma gangrenosum in ulcerative colitis patient treated with vedolizumab: adsorptive granulocyte/monocyte apheresis as a new therapeutic option refractory cases - a case report and literature review.
    Mastronardi M; Cavalcanti E; Labarile N; Armentano R; Gabriele F; Curlo M
    Ther Adv Chronic Dis; 2023; 14():20406223231194190. PubMed ID: 37928629
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Use of granulocyte/monocytapheresis in ulcerative colitis: A practical review from a European perspective.
    Domènech E; Grífols JR; Akbar A; Dignass AU
    World J Gastroenterol; 2021 Mar; 27(10):908-918. PubMed ID: 33776362
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Current pharmacologic treatment paradigms for inflammatory bowel disease and the potential role of granulocyte/monocyte apheresis.
    Schwartz D; Ferguson JR
    Curr Med Res Opin; 2007 Nov; 23(11):2715-28. PubMed ID: 17894921
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy and safety of granulocyte, monocyte/macrophage adsorptive in pediatric ulcerative colitis.
    Ruuska T; Küster P; Grahnquist L; Lindgren F; Wewer AV
    World J Gastroenterol; 2016 May; 22(17):4389-96. PubMed ID: 27158208
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Italian Registry of Therapeutic Apheresis: granulocyte-monocyte apheresis in the treatment of inflammatory bowel disease. A multicentric study.
    Passalacqua S; Ferraro PM; Bresci G; D'Ovidio V; Astegiano M; Principi M; Testa R; D'Incà R; Valpiani D; Armuzzi A; Sablich R; Cavallaro F; Costa F; Di Leo V; Colombo E; Santini A; Aratari A; Lecis P; Saladino V; Riegler G; Marco M; Calella F; Ricci C; Guidi ML; Repaci G; Silla M
    J Clin Apher; 2011 Dec; 26(6):332-7. PubMed ID: 22072543
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Changes in Treatment with Granulocyte and Monocyte Adsorptive Apheresis from the Past to Future in Patients with Inflammatory Bowel Disease.
    Kato S; Ishibashi A; Sugiura K; Kani K; Ogawa T; Hasegawa H; Yakabi K
    Contrib Nephrol; 2018; 196():200-208. PubMed ID: 30041228
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treatment options for children and adolescents with inflammatory bowel disease: is granulomonocytapheresis an effective alternative to drug therapy?
    Tanaka T; Yamamoto T; Sawada K; Sacco R
    Expert Rev Gastroenterol Hepatol; 2017 Aug; 11(8):749-758. PubMed ID: 28612637
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A randomised, double-blind, sham-controlled study of granulocyte/monocyte apheresis for moderate to severe Crohn's disease.
    Sands BE; Katz S; Wolf DC; Feagan BG; Wang T; Gustofson LM; Wong C; Vandervoort MK; Hanauer S
    Gut; 2013 Sep; 62(9):1288-94. PubMed ID: 22760005
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.